Cargando…
GPRC5A: An emerging prognostic biomarker for predicting malignancy of Pancreatic Cancer based on bioinformatics analysis
Background: Pancreatic cancer (PaCa) is a highly lethal malignancy. The treatment options for PaCa lack efficacy. The study aimed to explore the molecular biomarkers for predicting survival of PaCa and identify the potential carcinogenic mechanisms of the selected gene. Methods: Based on public data...
Autores principales: | Qian, Xuetian, Jiang, Chengfei, Shen, Shanshan, Zou, Xiaoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974517/ https://www.ncbi.nlm.nih.gov/pubmed/33753999 http://dx.doi.org/10.7150/jca.52578 |
Ejemplares similares
-
GPRC5A: An Emerging Biomarker in Human Cancer
por: Jiang, Xiaoxia, et al.
Publicado: (2018) -
The emerging roles of GPRC5A in diseases
por: Zhou, Honglei, et al.
Publicado: (2014) -
circGprc5a Promoted Bladder Oncogenesis and Metastasis through Gprc5a-Targeting Peptide
por: Gu, Chaohui, et al.
Publicado: (2018) -
IMUP and GPRC5A: two newly identified risk score indicators in pancreatic ductal adenocarcinoma
por: Wei, Rong, et al.
Publicado: (2021) -
MiR-103a-3p targets the 5′ UTR of GPRC5A in pancreatic cells
por: Zhou, Honglei, et al.
Publicado: (2014)